Laman UtamaMEHCQ • OTCMKTS
add
23andMe Holding Co
Tutup sebelumnya
$4.24
Julat hari
$4.05 - $4.39
Julat tahun
$0.47 - $10.81
Permodalan pasaran
117.60J USD
Bilangan Purata
575.71K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 45.15J | -29.49% |
Perbelanjaan pengendalian | 65.51J | -34.62% |
Pendapatan bersih | -99.35J | 52.43% |
Margin untung bersih | -220.04 | 32.54% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -45.06J | 35.08% |
Kadar cukai berkesan | 0.00% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 38.25J | -82.33% |
Jumlah aset | 159.89J | -59.54% |
Jumlah liabiliti | 186.64J | -9.68% |
Jumlah ekuiti | -26.74J | — |
Syer tertunggak | 27.54J | — |
Harga kepada buku | -4.37 | — |
Pulangan pada aset | -54.88% | — |
Pulangan pada modal | -230.70% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -99.35J | 52.43% |
Tunai daripada operasi | -40.73J | -57.97% |
Tunai daripada pelaburan | -734.00K | 65.80% |
Tunai daripada pembiayaan | -529.00K | -126.45% |
Perubahan bersih dalam tunai | -41.99J | -61.95% |
Aliran tunai bebas | -82.91J | -285.64% |
Perihal
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Diasaskan
Apr 2006
Ibu pejabat
Tapak web
Pekerja
261